Sugi Predict

Sugi Predict / Compounds / SCHEMBL330115

SCHEMBL330115

SCHEMBL330115

Nc1nc(C(F)(F)F)c(Br)s1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ EPHX2 P34913 1/20 0.35
▸ SCN4A P35499 1/20 0.35
▸ HPGD P15428 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ MPL P40238 2/20 0.31
▸ AXL P30530 1/20 0.31
▸ GFER P55789 1/20 0.31
▸ PRMT6 Q96LA8 1/20 0.30
▸ NOS1 P29475 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2497703 0.98 HSD17B10 (0.36) HSD17B10MEN1KMT2AMAPTALOX15
SCHEMBL77909 0.77 ALDH1A1 (0.42) HSD17B10MEN1KMT2AMAPTALOX15
SCHEMBL1897569 0.76 ALDH1A1 (0.39) HSD17B10MEN1KMT2AALOX15ALDH1A1
SCHEMBL20907837 0.74 MPL (0.42) HSD17B10ALOX15ALDH1A1EPHX2SCN4A
SCHEMBL965933 0.73 NOS1 (0.50) HSD17B10MEN1KMT2AMAPTALDH1A1
SCHEMBL4589608 0.73 ALDH1A1 (0.37) HSD17B10ALDH1A1EPHX2SCN4AHPGD
SCHEMBL2307680 0.73 ALDH1A1 (0.37) HSD17B10ALDH1A1EPHX2SCN4AHPGD
SCHEMBL6681331 0.73 ALDH1A1 (0.37) HSD17B10ALDH1A1EPHX2SCN4AHPGD
Bromide SCHEMBL2445772 0.71 COMT (0.42) MAPTALDH1A1
SCHEMBL12086420 0.70 HPGD (0.37) HSD17B10MEN1KMT2AALDH1A1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4745134-A1 PROTEIN ARGINASE METHYLTRANSFERASE-5 INHIBITOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2026-05-20 — — EP disclosed
WO-2025016323-A1 PROTEIN ARGINASE METHYLTRANSFERASE-5 INHIBITOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2025-01-23 — — WO disclosed
WO-2024217500-A1 ISOQUINOLINE COMPOUND, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF 上海赛默罗生物科技有限公司 2024-10-24 — — WO disclosed
CN-118359538-A Isoquinoline compound, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2024-07-19 — — CN disclosed
CN-112533917-B Morpholine derivatives as inhibitors of VPS34 神经孔疗法股份有限公司 2024-06-21 — — CN disclosed
EP-3774792-B1 MORPHOLINE DERIVATES AS INHIBITORS OF VPS34 NEUROPORE THERAPIES INC (US) 2022-09-14 — — EP disclosed
US-11236079-B2 Morpholine derivates as inhibitors of Vps34 NEUROPORE THERAPIES, INC. (US) 2022-02-01 — — US disclosed
US-20210300912-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF Ikena Oncology, Inc. 2021-09-30 — — US disclosed
US-20210300912-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF Ikena Oncology, Inc. 2021-09-30 — — US disclosed
WO-2021127302-A1 2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS Ikena Oncology, Inc. (US) 2021-06-24 — — WO disclosed
EP-1514544-A1 ANTIALLERGIC Institute of Medicinal Molecular Design, Inc. (JP) 2005-03-16 — — EP disclosed
EP-1512396-A1 INHIBITORS AGAINST THE ACTIVATION OF AP-1 AND NFAT Institute of Medicinal Molecular Design, Inc. (JP) 2005-03-09 — — EP disclosed
EP-1510210-A1 IMMUNITY-RELATED PROTEIN KINASE INHIBITORS Institute of Medicinal Molecular Design, Inc. (JP) 2005-03-02 — — EP disclosed
EP-1510207-A1 THERAPEUTIC DRUG FOR DIABETES Institute of Medicinal Molecular Design, Inc. (JP) 2005-03-02 — — EP disclosed
US-20040259877-A1 Inhibitors against the production and release of inflammatory cytokines INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2004-12-23 — — US disclosed
WO-2004056177-A2 INSECTICIDAL AMINOTHIAZOLE DERIVATIVES NIPPON SODA CO. LTD. (JP) 2004-07-08 — — WO disclosed
US-6737382-B1 WIDE SPECTRUM OF PLANT PROTECTING ACTIVITY NIPPON SODA CO. LTD. (JP) 2004-05-18 — — US disclosed
US-20040082629-A1 INSECTICIDAL AMINOTHIAZOLE DERIVATIVES NIPPON SODA CO., LTD. 2004-04-29 — — US disclosed
CN-1489458-A Inflammatory cytokine production dissociation inhibitor ��ʽ����ҽҩ��������о��� 2004-04-14 — — CN disclosed
EP-1352650-A1 INHIBITORS AGAINST THE PRODUCTION AND RELEASE OF INFLAMMATORY CYTOKINES Institute of Medicinal Molecular Design, Inc. (JP) 2003-10-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300912-A1 ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS AND USES THEREOF AHR, ARNT, HCAR1 HSD17B10 329/4885MEN1 4851/4885KMT2A 1031/4885
US-20040082629-A1 INSECTICIDAL AMINOTHIAZOLE DERIVATIVES SCN7A, SCN2B, CASP7 HSD17B10 1046/4885MEN1 4500/4885KMT2A 1863/4885
US-20040259877-A1 Inhibitors against the production and release of inflammatory cytokines NFKBIA, IL1B, IKBKB HSD17B10 704/4885MEN1 4661/4885KMT2A 4095/4885
US-11236079-B2 Morpholine derivates as inhibitors of Vps34 VPS35, TFEB, VPS4B HSD17B10 3089/4885MEN1 3272/4885KMT2A 3747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.